Join us for our next Live-talk Thursday, August 18, at 3:00 pm PST. for great conversation and compelling guests. You can read more about Live Talk here, and Listen to our past sessions on demand here.
Articles of note for people dealing with pituitary disease and related conditions.
Join a drug trial. Find out how. Here’s a partial list of studies.
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Live talk, session 12 – August 4, 2022: Residual and recurring Cushing’s
It's always fascinating to listen to two of the recognized experts and leading clinicians in Cushing's disease discuss their experiences with the disease and patients. In this Live Talk session, Pituitary World New's innovative program for education and awareness, Dr. Kevin Yuen and Dr. Lewis Blevins bring an intimate, revealing look at their approaches to Cushing's disease and syndrome. The discussion focuses on their experiences and how they think about their patients, and the options they have available for treatment. Listen and learn their views on each available drug to treat the disease and their rationale for recommending treatment options. And don't miss the discussion on access to those medications, including insurance coverage issues, towards the end of the session. Enjoy!
What’s all this noise we hear about the voice of the patient?
An opinion editorial from J D Faccinetti, co-founder, on listening and interpreting without influencing – Progressive, innovative enterprises have been
News In Brief
LIVE TALK sessions are now available on Demand. Click here to listen to past shows.
From Recordati Rare Diseases Phase III study confirms the efficacy and safety of ISTURISA®. achieving sustained cortisol control in the majority of patients. Read more
Good news from Amryt Pharma for acromegaly patients in Europe. Read the release from Amryt Pharma on Mycapssa® here.
Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome. Click here to learn more and see if you qualify.
Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study. To learn more about the trial and see if you qualify Read more here
Read more about clinical trials from Xeris Pharma, Camurus AB, and Ionis Ph
Content for physicians and healthcare professionals.
The latest from pharmaceutical companies and related organizations
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Listen to Dr. Tamara Wexler, a nationally recognized neuroendocrinologist and expert in pituitary dysfunction after a brain injury. She joins Dr. Lewis Blevins in this eye-opening podcast.
I'm happy to welcome Leslie Edwin, president of Cushing's Support and Research Foundation (CSRF), to our microphones. The CSRF is a leading Cushing's disease and syndrome patient support organization.
Mental health and emotional wellness are essential topics for pituitary patients, their families, and friends. This on-demand session from last Thursday's live-talk program focuses on the challenges and opportunities when considering these issues.
Subscribe & Listen
Apple Podcasts
Spotify
Amazon Music
Google PodcastsLive Talk on Demand
Most Popular Articles
Events
If you missed the recent Acromegaly Community Hybrid Educational Conference May 20-22, 2022 here’s a link to watch some of the presentations
